Vascular endothelial growth factor receptor 1 morpholino decreases angiogenesis in a murine corneal suture model

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 2, 2012, Pages 685-692

  Cho, Yang Kyung ^a,b   Uehara, Hironori ^a   Young, Jason R ^a   Archer, Bonnie ^a   Zhang, Xiaohui ^a   Ambati, Balamurali K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHOLINO OLIGONUCLEOTIDE; RNA PRECURSOR; VASCULOTROPIN RECEPTOR 1;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CORNEA NEOVASCULARIZATION; DISEASE MODEL; GENETICS; METABOLISM; MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUTURE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED BALB C; MORPHOLINOS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PRECURSORS; SUTURES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84859253128     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8391     Document Type: Article

References (33)

1. Maddula S, Davis DK, Maddula S, Burrow MK, Ambati BK. Horizons in therapy for corneal angiogenesis. Ophthalmology. 2011;118: 591-599.
2. Rocher N, Behar-Cohen F, Pournaras JA, et al. Effects of rat anti- VEGF antibody in a rat model of corneal graft rejection by topical and subconjunctival routes. Mol Vis. 2011;17:104-112.
3. Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004;113:1040-1050.
4. Santos LN, de Moura LR, Fernandes BF, Cheema DP, Burnier MN Jr. Histopathological study of delayed regraft after corneal graft failure. Cornea. 2011;30:167-170.
5. Weisbrod DJ, Sit M, Naor J, Slomovic AR. Outcomes of repeat penetrating keratoplasty and risk factors for graft failure. Cornea. 2003;22:429-434.
6. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signaling: in control of vascular function. Nat Rev Mol Cell Biol. 2006;7:359-371.
7. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature. 2005;438:967-974.
8. Wu FTH, Stefanini MO, Mac Gabhann F, Kontos CD, Annex BH, Popel AS. A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. J Cell Mol Med. 2010;14(3):528-552; doi:10.1111/j.1582- 4934.2009.00941.x.
9. Shibuya M. Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1). Int J Biochem Cell Biol. 2001;33: 409-420.
10. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol. 2006;39:469-478.
11. Kerber M, Reiss Y, Wickersheim A, et al. Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Res. 2008;68: 7342-7351.
12. Huckle WR, Roche RI. Post-transcriptional control of expression of sFlt-1, an endogenous inhibitor of vascular endothelial growth factor. J Cell Biochem. 2004;93:120-132.
13. Rahimi N, Golde TE, Meyer RD. Identification of ligand-induced proteolytic cleavage and ectodomain shedding of VEGFR-1/FLT1 in leukemic cancer cells. Cancer Res. 2009;69:2607-2614.
14. Heasman J. Morpholino oligos: making sense of antisense? Dev Biol. 2002;243:209-214.
15. Ekker SC, Larson JD. Morphant technology in model developmental systems. Genesis. 2001;30:89-93.
16. Summerton J, Weller D. Morpholino antisense oligomers: design, preparation, and properties. Antisense Nucleic Acid Drug Dev. 1997;7:187-195.
17. Summerton J. Morpholino antisense oligomers: the case for an RNase H-independent structural type. Biochim Biophys Acta. 1999;1489:141-158.
18. Summerton JE. Morpholino, siRNA, and S-DNA compared: impact of structure and mechanism of action on off-target effects and sequence specificity. Curr Top Med Chem. 2007;7:651-660.
19. Morcos PA, Li Y, Jiang S. Vivo-morpholinos: a non-peptide transporter delivers morpholinos into a wide array of mouse tissues. BioTechniques. 2008;45:613-623.
20. Moulton JD, Jiang S. Gene knockdowns in adult animals: PPMOs and vivo-morpholinos. Molecules. 2009;14:1304-1323.
21. Singh N, Amin S, Richter E, et al. Flt-1 intraceptors inhibit hypoxiainduced VEGF expression in vitro and corneal neovascularization in vivo. Invest Ophthalmol Vis Sci. 2005;46:1647-1652.
22. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25:581-611.
23. Ambati BK, Nozaki M, Singh N, et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature. 2006;443:993-997.
24. Mittar S, Ulyatt C, Howell GJ, et al. VEGFR1 receptor tyrosine kinase localization to the Golgi apparatus is calcium-dependent. Exp Cell Res. 2009;315:877-889.
25. Cai J, Jiang WG, Grant MB, Boulton M. Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem. 2006;281:3604-3613.
26. Rahimi N, Golde TE, Meyer RD. Identification of ligand-induced proteolytic cleavage and ectodomain shedding of VEGFR-1/FLT1 in leukemic cancer cells. Cancer Res. 2009;69:2607-2614.
27. Wu B, Li Y, Morcos PA, Doran TJ, Lu P, Lu QL. Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice. Mol Ther. 2009;17:864-871.
28. Hodson S, Kaila D, Hammond S, Rebello G, al-Omari Y. Transient chloride binding as a contributing factor to corneal stromal swelling in the ox. J Physiol. 1992;450:89-103.
29. Bonduelle CV, Gillies ER. Dendritic guanidines as efficient analogues of cell penetrating peptides. Pharmaceuticals. 2010;3: 636-666; doi:10.3390/ph3030636.
30. Maruyama K, Ii M, Cursiefen C, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest. 2005;115:2363-2372.
31. Nakao S, Kuwano T, Tsutsumi-Miyahara C, et al. Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 betainduced neovascularization and tumor growth. J Clin Invest. 2005; 115:2979-2991.
32. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem. 1995;270:12607-12613.
33. Hos D, Saban DR, Bock F, et al. Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids. Arch Ophthalmol. 2011;129:445-452.